首页> 外国专利> Macrocyclic compounds as inhibitors of viral Replication, Pharmaceutical compositions containing them and their use in the treatment of Viral Infections.

Macrocyclic compounds as inhibitors of viral Replication, Pharmaceutical compositions containing them and their use in the treatment of Viral Infections.

机译:大环化合物作为病毒复制的抑制剂,含有它们的药物组合物及其在治疗病毒感染中的用途。

摘要

ILO, c2-6 alquenilo, C1-6 alcoxi, hidroxi-c1-6 acquilo, C1-6 optional tar, replaced by haen, containing 5 fluorocarbons in various functions, C1-6 alcoxi optional alternative general formula (1) - (19),And compounds, including FA compounds below 5 fluorination; or R21 is pyridyl Dan, pyridyl Dan, RMA, including a compound of mepirazi Nile, Tianjin, furan, sulfuryl hydrazide, oxazolilo, which can be used for treating infertility, phenyl or sulfuryl; and R22 is C1-6 tar, C3 flash memory compound, Including infectious monocyclopentadiol 7, c4-10 propyl propyl tar, all of which are optional substitutes for hepatitis C virus, and three times of treatment of fibrosis with halide, cyanide, nitric acid and hydroxyl,C1-6 liver. Claim 1: A compound characterized in that it has the formula (1): wherein Q is an aalkyl optionally substituted with up to 5 fluoro, or phenyl. Claim 200: A central caranillo compound that is selected from the remains of formulas (2) where the central ring can be jaundred because it has the formula (14) where Q is a central ring that is selected from those substituted or substituted with H, halo , cyano, nitro, hydroxy, C1-6 alkyl, C3-7 cycloalkyl, C4-10 os of formulas (11) where the central ring can alkylcycloalkyl, C2-6 alkenyl, C1-6 alkoxy, be unsubstituted or substituted with H, halo, cyano, idroxy C1-6 alkyl, C1-6 alkyl,Or an oxy, Cilo, Mino, hydrocarbon, carboxilo,Cyclopentadiene, cyclopentadiene, sulfur, sulfur oxide, sulfur, amino group, epoxicopropylene, epoxicopropylene or ethylene oxide, epoxicopropylene, leasing, cyclopropenyl acrylonitrile, or q is R1-R2, wherein R1 earboxi, carbide, cyclopentadiene spiral, epoxicopropylene, C1-6 spiral cyclopropene Tar, C3-7 cyclopropene, C4-10 cyclopropene, phenyl, pyridine, pyridine, pyridine, pyridine,o ciclohexilo espiroc clico o Q es R1-R2 donde R1 es C1-6 alquilo C3-7 cicloalquilo C4-10 alqu piridazina pirrol furano tiofeno tiazol oxazol imidazol isoxazol pirazol isotiazol naftililcicloalquilo fenilo piridina pirazina pirimio quinolina isoquinolina quinoxalina benzotiazdina piridazina pirrol furano tiofeno tiazol ol each optionally substituted with haso, C3-7 cycloalkyl, C4-10 alkylcycloalkyl, C2ta three NR6R7, halo, cyano, nitro, hydroxy, C1-6 to -6 alkenyl, C1-6 alkoxy, hydroxy-C1-6 alkyl, or C1-6 alkyl optionally substituted with up to 5 alkyl, C3-7 cycloalkyl, C4-10 alkylcycloalkyl, C2-6 alkenyl, C1-6 alkoxy, hydroxy-C1-6 alkyl fluoro, C1-6 alkoxy optionally substituted with it, C1-6 alkyl optionally substituted with hasthasta 5 fluoro; and R2 is H, phenyl, pyridine, pyrazine, 5-fluoro, or C1-6 optionally substituted alkoxy, pyrimidine, pyridazine, pyrrole, furan, thiophene with up to 5 fluoro; and R2 is H, phenyl, pyridine, no, thiazole, oxazole, imidazole, isoxazole, pyrazole,ipirazine, pyrimidine, pyridazine, pyrrole, furan, sothiazole, naphthyl, quinoline, isoquinoline, quinoxaline, benzothiazole, benzothiophene, benzofuran, indtiofen, thiazole, oxazole, imidazole, isoxazole, pyrazole, isothiazole, quinoline, naphthyl, benzimine, quinoline , each optionally substituted with up to three NR6R7, halo, cyano, nitro, hydruinoxaline, benzothiazole, benzothiophene, benzofuran, indole, benzimidazole, each optionally sustoxy, C1-6 alkyl, C3-7 cycloalkyl, C4-10 alkylcycloalkyl, C2- 6 alkenyl, C1-6 alkoxy, hydroxy substituted with up to three NR6R7, halo, cyano, nitro, hydroxy, C1-6 alkyl, C3-7 cycloalkyl, C4-10 alq-C1-6 alkyl,C1-6 alkyl optionally substituted with up to 5 fluoro, or C1-6 alkoxy optionally alkylcycloalkyl, C2-6 alkenyl, C1-6 alkoxy, hydroxy-C1-6 alkyl, C1-6 alkyl optionally substituted with up to 5 fluoro; R4 is H, C1-6 alkylated with up to 5 fluoro, or C1-6 alkoxy optional, C3-7 cycloalkyl, C4-10 alkylcycloalkyl, phenyl, or benzyl, said phenyl or benzyl substituted with up to 5 fluoro; R4 is H, C1-6 alkyl, C3-7 cycloalkyl, C4-10 alkylcycloalkyl substituted by up to three halo, cyano, nitro, hydroxy, C1-6 alkyl, C3-7 cycloalkyl, C4-10 or, phenyl, or benzyl, said phenyl or benzyl optatalkylcycloalkyl, C2-6 alkenyl, C1-6 alkoxy,Hively substituted by up to three halo, cyano, nitro, hydroxy, C1-6 alkyl, C3-7 cycloalkyl, C4-idroxy-C1-6 alkyl, C1-6 alkyl optionally substituted with up to 5 fluoro, or C1-6 alkoxy optativ10 alkylcycloalkyl , C2-6 alkenyl, C1-6 alkoxy, hydroxy-C1-6 alkyl, C1-6 alkyl optionally substituted with up to 5 fluoro; R5 is H, C1- substituted with up to 5 fluoro, or C1-6 alkoxy opta6 alkyl, C (O) NR6R7, C (S) NR6R7, C (O) R8, C (O) OR8, S (O) 2R8, or (CO) CHR21NH (CO) R22; R6 and R7 are each uniquely substituted with up to 5 fluoro; R5 is C1-6 alkyl, C (O) NR6R7, C (S) NR6R7, C (O) R8, C (O) OR8, or independently H, C1-6 alkyl, C3-7 cicS (O) 2R8 , or (CO) CHR21NH (CO) R22;R6 and R7 are each unloalkyl, C4-10 alkylcycloalkyl, or phenyl, said phenyl optionally substituted by up to three or independently H, C1-6 alkyl, C3-7 cyclo, cyano, nitro, hydroxy, C1-6 alkyl, C3 -7 cycloalkyl, C4-10 alkylcycloalkyl, or phenyl, said phenyl optionally substituted by up to three chloalkyl, C4-10 alkylcycloalkyl, C2-6 alkenihalo, cyano, nitro, hydroxy, C1-6 alkyl, C3-7 cyclo, hydroxy-C1 -6 alkyl, C1-6 alkyl optionally substituted with up to 5 fluoro, or C1-6 alkoxy opcloalkyl, C4-10 alkylcycloalkyl, C2-6 alkenatively substituted with up to 5 fluoro; or R6 and lo, hydroxy-C1-6 alkyl,C1-6 can be optionally replaced by C1-6 tar with no more than 5 fluorination, or C1-6 alcoxi compressive 7, which is used with N and is combined with N, which is temporarily replaced by a substance with no more than 5 fluorination; or R6 and formed Indian forest, pyridinol, pyridinediol, pyridinediol, picolinate or morphine alcohol; R8 is C1-6 tar, which is combined with N, is combined with N, and is combined with P c3-7 cyclopentyl glycol, C4-10.c4-10.acquilcoalquilo, todoro formula indolilo, pirrolidini, piperiazinilo, O morfolinil; R8 is C1-6 tar, and halogen, cyanogen, nitrate, hydroxyl, c-3-7 cycloquilo, c4-10 quilcoalquilo can be used instead of 1-6 alcoxi, all of which are optional substitutes, O phenyl;or R8 is C6 or 10 aryl which is optionally substituted by up to three halo, cyano and three times with halo, cyano, nitro, hydroxy, Cno, nitro, hydroxy, C1-6 alkyl, C3-7 cycloalkyl1-6 alkoxy, or phenyl ; or R8 is C6 or 10 aryl than that, C4-10 alkylcycloalkyl, C2-6 alkenyl, C1-6 optionally substituted by up to three halo, cyano, nitro, hydroxy, C1-6 alkyl, C3-7 cycloalkylalkoxy, C1-6 hydroxy alkyl, C1-6 optional alkyl, C4-10 alkylcycloalkyl, C2-6 alkenyl, C1-6 substituted with up to 5 fluoro, or C1-6 alkoxy optionally substituted with up to 5 fluoro; or Ralcoxi, hydroxy-C1-6 alkyl,C1-6 optional C1-6 tar 8 is a C1-6 tar, which is replaced by a substance below 5 fluorination, or by a substance 5 fluorination, or by a substance 5 fluorination; or R8 is a C1-6 tetrahydrogen ring structure, which can optionally be replaced by hasourano through a tetrahydrofuran ring structure C3 or C4; R8 is a large teapot ring composed of five fluorine groups, or R8 is a tetrahydrazine ring connected by the combined cation position of tetrahydrofuran ring C3 or C4, or R8 is a large teapot ring composed of tetrahydropyridin ring, which is a toluenediamide connected by the C4 position of anila-c (o) NHS (o) 2r9,where R9 is C1-6 alkyl, C3-7l tetrapiranyl; And it is COOR9, where R9 is C1-6 to the cycloalkyl, or C4-10 alkylcycloalkyl, all of which are optionally substituted between a chyl; or Y is a sulfonimide of the formula -C (O) NHS (O) 2R9, where R9 is C1-3 alkyl, C3-7 cycloalkyl three times with halo, cyano, nitro, hydroxy, C1-6yl, or phenyl which is optionally substituted by alkoxy, or phenyl; or R9 is C6 or 10 aryl which is ophasta two halo, cyano, nitro, hydroxy, C1-3 alkyl substituted by up to three halo, cyano, or, C3-7 cycloalkyl, or C1-3 alkoxy, or Y is a nitro acid , hydroxy, C1-6 alkyl, C3-7 cycloalkyl, C4-10 alkylcycloalkyl, C2-6 alkenyl, C1-6 carboxylic aldo;P = 0 or 1; V and W are selected from O, s or NH respectively; Cox line, C1-6 tar or C1-6 tar selected from script represent an additional double-layer combination, replaced by C1-6 alcox with no more than 5 fluorination;R21 is a C1-6 tar, c3-7 cyclopropylsulfonate, c4-10 heterogeneous substitute, with a maximum of 5 fluorination; or R9 quilcoalquilo, all of which are optional C1-6 tar, with a maximum of 5 fluorination group, nr6r7, nr1ar1b, O (CO) Oh; or 1-3 to 3 times with halogen, cyanogen, nitric acid, hydrocarbon, C1-6 alcox, C1-6 or 9 light substitutes. This is an alternative heteroaromatic ring with up to 5 fluorinated or phenyl substituted
机译:ILO,c2-6阿克洛尼洛,C1-6阿克洛西,hidroxi-c1-6阿奎洛基,C1-6任选焦油,被haen取代,含有5种碳氟化合物,具有各种功能,C1-6阿尔克辛任选通式(1)-(19 )和化合物,包括5以下氟化的FA化合物;或R 21为吡啶基Dan,吡啶基Dan,RMA,包括可用于治疗不育症的苯基吡咯啉,呋喃基,呋喃基,硫酰肼,恶唑啉的化合物,其可用于治疗不育症。 R22是C1-6焦油,C3快闪化合物,包括传染性单环戊二醇7,c4-10丙基丙基焦油,它们都是丙型肝炎病毒的可选替代品,并用卤化物,氰化物,硝酸对纤维化进行了三次治疗和羟基,C1-6肝。权利要求1的化合物,其特征在于其具有式(1):其中Q是任选被至多5个氟或苯基取代的芳烷基。权利要求200:中心式化合物,其选自式(2)的残基,其中中心环可被黄化,因为它具有式(14)其中Q是中心环,其选自由H取代或取代的环;式(11)的卤素,氰基,硝基,羟基,C 1-6烷基,C 3-7环烷基,C 4-10 os,其中中心环可以未被取代或被H取代的烷基环烷基,C 2-6烯基,C 1-6烷氧基,卤素,氰基,异氧C 1-6烷基,C 1-6烷基或氧,Cilo,Mino,烃,羧酸,羧基,环戊二烯,环戊二烯,硫,氧化硫,硫,氨基,环氧丙烯,环氧丙烯或环氧乙烷,环氧丙烯,租赁,环丙烯基丙烯腈或q为R1-R2,其中R1伯碳,碳化物,环戊二烯螺旋,环氧丙烯,C1-6螺旋环丙烯焦油,C3-7环丙烯,C4-10环丙烯,苯基,吡啶,吡啶,吡啶,吡啶环丙沙星螺环酯Q es R1-R2 donde R1 es C1-6 alquilo C3-7 ciclo alquilo C4-10 alqu piridazina pirrol呋喃诺tiofeno tiazol oxazol咪唑异恶唑pirazol isotiazol naftililcicloalquilo fenilo piridina pirazina pirimio quinolina异喹啉基quinoxalina苯并噻吩并三烷基C7-10环烷基萘基卤素,氰基,硝基,羟基,C 1-6至-6烯基,C 1-6烷氧基,羟基-C 1-6烷基或C 1-6烷基,可选地被多达5个烷基,C 3-7环烷基,C 4-10烷基环烷基取代,C 2-6烯基,C 1-6烷氧基,羟基-C 1-6烷基氟,任选地被其取代的C 1-6烷氧基,任选地被哈萨斯塔5氟取代的C 1-6烷基; R 2是H,苯基,吡啶,吡嗪,5-氟或C 1-6任选取代的烷氧基,嘧啶,哒嗪,吡咯,呋喃,噻吩,具有至多5个氟;和R2为H,苯基,吡啶,否,噻唑,恶唑,咪唑,异恶唑,吡唑,吡拉嗪,嘧啶,哒嗪,吡咯,呋喃,噻唑,萘基,喹啉,异喹啉,喹喔啉,苯并噻唑,苯并噻吩,苯并呋喃,茚满,恶唑,咪唑,异恶唑,吡唑,异噻唑,喹啉,萘基,苯并明,喹啉,各自任选被多达三个NR6R7,卤素,氰基,硝基,联苯并恶唑啉,苯并噻唑,苯并噻吩,苯并呋喃,吲哚,苯并咪唑C 1-6烷基,C 3-7环烷基,C 4-10烷基环烷基,C 2-6烯基,C 1-6烷氧基,被最多三个NR 6 R 7取代的羟基,卤素,氰基,硝基,羟基,C 1-6烷基,C 3-7环烷基,C4-10烷基-C1-6烷基,C1-6烷基(可选被最多5个氟取代)或C1-6烷氧基(可选)烷基环烷基,C2-6烯基,C1-6烷氧基,羟基-C1-6烷基,C1- 6个烷基,任选地被最多5个氟取代; R4是H,C1-6被最多5个氟取代的烷基,或C1-6烷氧基任选的,C3-7环烷基,C4-10烷基环烷基,苯基或苄基,所述苯基或苄基被最多5个氟取代; R4是H,C1-6烷基,C3-7环烷基,C4-10烷基环烷基,最多被三个卤素,氰基,硝基,羟基,C1-6烷基,C3-7环烷基,C4-10或苯基或苄基取代,所述的苯基或苄基的优选烷基环烷基,C 2-6烯基,C 1-6烷氧基,被最多三个卤素,氰基,硝基,羟基,C 1-6烷基,C 3-7环烷基,C 4-环氧-C 1-6烷基取代,任选被至多5个氟取代的C 1-6烷基,或任选被至多5个氟取代的C 1-6烷氧基Optativ 10烷基环烷基,C 2-6烯基,C 1-6烷氧基,羟基-C 1-6烷基,C 1-6烷基; R5是H,被最多5个氟取代的C1-或C1-6烷氧基opta6烷基,C(O)NR6R7,C(S)NR6R7,C(O)R8,C(O)OR8,S(O)2R8 ,或(CO)CHR21NH(CO)R22; R6和R7各自被最多5个氟唯一取代; R 5是C 1-6烷基,C(O)NR6R7,C(S)NR6R7,C(O)R8,C(O)OR8或独立地是H,C 1-6烷基,C3-7 cicS(O)2R8或(CO)CHR21NH(CO)R22; R6和R7各自为单烷基,C4-10烷基环烷基或苯基,所述苯基可选地被多达三个或独立地由H,C1-6烷基,C3-7环,氰基,硝基,羟基,C1-6烷基,C3-7环烷基,C4-10烷基环烷基或苯基,所述苯基任选地被至多三个氯烷基,C4-10烷基环烷基,C2-6烯基卤代,氰基,硝基,羟基,C1-6烷基,C3-7环,羟基-C1-6烷基,C1-6取代任选地被最多5个氟取代的烷基,或C 1-6烷氧基对甲基烷基,C 4-10烷基环烷基,被最多5个氟取代的C 2-6;或R 6和L 1,羟基-C 1-6烷基,C 1-6可以任选地被氟化程度不超过5的C 1-6焦油或与N一起使用并与N结合的C 1-6醇抗压剂7取代,暂时用氟化度不超过5的物质代替;或R6,形成印度森林,吡啶醇,吡啶二醇,吡啶二醇,吡啶甲酸或吗啡醇;或R8是C1-6焦油,它与N结合,与N结合,并与P c3-7环戊二醇,C4-10.c4-10.acquilcoalquilo,todoro配方吲哚洛,吡咯咯地尼,哌齐嗪罗,O morfolinil结合; R8是C1-6焦油,可以使用卤素,氰,硝酸盐,羟基,c-3-7环喹啉,c4-10 quilcoalquilo代替1-6醇氧,所有这些都是可选的替代品,O苯基;或者R8是C 6或10个芳基,其任选地被最多三个卤素,氰基取代,并被卤素,氰基,硝基,羟基,Cno,硝基,羟基,C 1-6烷基,C 3-7环烷基1-6烷氧基或苯基取代三次;或R 8是C 6或10个芳基,C 4-10烷基环烷基,C 2-6烯基,C 1-6任选被至多三个卤素,氰基,硝基,羟基,C 1-6烷基,C 3-7环烷基烷氧基,C 1-6取代羟基烷基,C 1-6任选烷基,C 4-10烷基环烷基,C 2-6烯基,被最多5个氟取代的C 1-6或任选被最多5个氟取代的C 1-6烷氧基;或者Ralcoxi,羟基-C 1-6烷基,C 1-6任选的C 1-6焦油8是C 1-6焦油,其被5氟化以下的物质,5氟化的物质或5氟化的物质代替;或R 8为C 1-6四氢环结构,其可任选地通过四氢呋喃环结构C 3或C 4被hasourano取代; R 8是由五个氟基团组成的大茶壶环,或R 8是由四氢呋喃环C 3或C 4的结合阳离子位置连接的四肼环,或R 8是由四氢吡啶环组成的大茶壶环,其为甲苯二酰胺,通过芳基-c(o)NHS(o)2r9的C4位,其中R9为C1-6烷基,C3-7l四吡喃基;并且它是COOR9,其中R9是环烷基的C1-6或C4-10烷基环烷基,所有这些都任选地被取代在苯基之间;或Y是式-C(O)NHS(O)2 R 9的磺酰亚胺,其中R 9是C 1-3烷基,C 3-7环烷基,三倍是卤素,氰基,硝基,羟基,C 1-6基或苯基。任选地被烷氧基或苯基取代;或R 9为C 6或10芳基,其为两个卤素,氰基,硝基,羟基,被最多三个卤素,氰基取代的C 1-3烷基,或C 3-7环烷基或C 1-3烷氧基,或Y为硝基酸,羟基,C 1-6烷基,C 3-7环烷基,C 4-10烷基环烷基,C 2-6烯基,C 1-6羧基醛基; P = 0或1; V和W分别选自O,s或NH;从脚本中选择的Cox线,C1-6焦油或C1-6焦油代表附加的双层组合,被不超过5个氟化的C1-6醇铝取代; R21是C1-6焦油,c3-7环丙基磺酸盐,c4 -10个异构替代物,最多氟化5个;或R9 quilcoalquilo,它们都是可选的C1-6焦油,最多带有5个氟化基团,nr6r7,nr1ar1b,O(CO)哦;或与卤素,氰,硝酸,碳氢化合物,C1-6醇,C1-6或9种轻替代品混合1-3至3次。这是一个杂芳环,具有最多5个氟化或苯基取代的杂芳环

著录项

  • 公开/公告号AR050321A1

    专利类型

  • 公开/公告日2006-10-18

    原文格式PDF

  • 申请/专利权人 INTERMUNE INC.;

    申请/专利号AR2005P101257

  • 发明设计人

    申请日2005-03-30

  • 分类号C07D487/04;A61K31/495;A61P31/14;C07D487/04;C07D245/00;C07D221/00;C07D513/04;C07D277/00;

  • 国家 AR

  • 入库时间 2022-08-21 21:40:23

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号